Clinical and Pharmacokinetic Outcomes of Peak–Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial-Reference-Cited by-同舟云学术

Clinical and Pharmacokinetic Outcomes of Peak–Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial

Published:2019-03-27 Issue:5 Volume:44 Page:639-652
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Al-Sulaiti Fatima Khalifa,Nader Ahmed Mohamed,Saad Mohamed Omar,Shaukat Adila,Parakadavathu Rakesh,Elzubair Ahmed,Al-Badriyeh Daoud,Elewa Hazem,Awaisu Ahmed^ORCID

Funder

Qatar University

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s13318-019-00551-1.pdf

Reference75 articles.

1. Bauer LA. Applied clinical pharmacokinetics. 3rd ed. USA: McGraw Hill; 2014.

2. Neely MN, Youn G, Jones B, Jelliffe RW, Drusano GL, Rodvold KA, et al. Are vancomycin trough concentrations adequate for optimal dosing? Antimicrob Agents Chemother. 2014;58(1):309–16.

3. Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82–98.